+499.5%
MRNA vs CNP
+7.2%
+492.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CNP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.8% | -1.5% | -2.6% |
| 7D | +5.5% | +1.1% | +4.4% | +6.0% |
| 30D | +158.7% | -1.8% | +160.6% | +158.3% |
| 3M | +182.1% | -4.6% | +186.8% | +181.1% |
| 6M | +151.8% | -8.8% | +160.7% | +157.0% |
| YTD | +393.6% | +5.2% | +388.3% | +370.4% |
| 1Y | +499.5% | +8.3% | +491.2% | +495.1% |
| All | +499.5% | +7.2% | +492.2% | +495.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CNP.
Daily Out/Under-Performance
Portfolio return minus CNP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CNP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CNP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling